GlaxoSmithKline Forecast To Get £3 Billion From Swine Flu

The H1N1 outbreak will certainly be good news for the pharmaceutical groups, but just how good remains a mystery as the firms supplying the vaccines and treatments, and the governments buying them, refuse to give details on how much it is all costing. Whilst GlaxoSmithKline will not say how much it expects to earn from swine flu, analysts put the figure at between £1bn and £3bn.
One Click Note: If the UK media fail to reveal the FOIA financial information on the UK government spend on Swine Flu - a crucial point of interest for ALL of their respective audiences - this will represent yet another propaganda and prostitution nail in their coffin.
Alistair Dawber, The Independent/The One Click Group
Related Links:

* GSK’s Pandemrix Swine Flu Vaccine- Pandora's Box Release

Lara, Health Advocate



Data Shows Flu Shots Precipitate Swine Flu - Canada Cancels Programme

Pharmacy worker Victor Galindez holds doses of the H1N1 flu vaccine at Montefiore Medical Center in the Bronx borough of New York City on Tuesday

TORONTO -- An unpublished Canadian study that suggests getting an annual flu shot may make it easier to contract swine flu has caused most provincial governments in Canada to postpone or limit seasonal-flu vaccination programs. The study is co-authored by researchers from the British Columbia Centre for Disease Control, the Ontario Agency for Health Protection and Promotion and Laval University in Quebec. Twelve of Canada's 13 provinces and territories are delaying the rollout of seasonal-flu shots for the bulk of their populations. "Why would you want to run the risk of doubling peoples' risk of getting H1N1?" said Dr Perry Kendall, provincial health officer for British Columbia, who noted that he has seen the data and talked to the study's authors.

The Wall Street Journal, Phred Dvorak & Betsy McKay



200 Hundred Families Demonstrate Against Vaccines UK

The timely organisation of a protest in London by a couple of groups called Vaccine Risk Awareness and Arnica set the ball rolling for a good many parents including myself to gather up their banners and head to Old Palace Yard outside Parliament. A syringe is now seen as a symbol of safety, no longer associated to pain or illness but to protection. However my own view altered the day I saw my own toddler son regress into severe autism after a routine childhood jab. The sight of newborns, and small children at the demo reinforced the important decisions parents want to maintain power over - the right to choose whether or not to have immunisations themselves and for their offspring.

Allison Edwards, Parent Advocate